Article
Re-Thinking 'Product Claim' DTCA in the United States: Implications for Regulation and Public Health
2026-02-27
Abstract excerpt
The United States is one of only two countries worldwide that permits direct-to-consumer advertising (DTCA) of prescription drugs, yet policy debates treat this practice as a monolithic construct. Insufficient distinction has been made among DTCA's three regulatory categories: help-seeking, reminder, and "Product Claim" advertisements. This paper argues that "Product Claim" advertisements - which explicitly name d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 67031e91-216d-535e-ac9b-613aa3de470c
- DOI
- 10.20944/preprints202602.1756.v1
